These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 12926601)

  • 21. Fat compartments and apolipoprotein B-100 kinetics in overweight-obese men.
    Watts GF; Chan DC; Barrett PH; Susekov AV; Hua J; Song S
    Obes Res; 2003 Jan; 11(1):152-9. PubMed ID: 12529498
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human apolipoprotein (Apo) B-48 and ApoB-100 kinetics with stable isotopes.
    Welty FK; Lichtenstein AH; Barrett PH; Dolnikowski GG; Schaefer EJ
    Arterioscler Thromb Vasc Biol; 1999 Dec; 19(12):2966-74. PubMed ID: 10591677
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipoprotein Metabolism in APOB L343V Familial Hypobetalipoproteinemia.
    Hooper AJ; Heeks L; Robertson K; Champain D; Hua J; Song S; Parhofer KG; Barrett PH; van Bockxmeer FM; Burnett JR
    J Clin Endocrinol Metab; 2015 Nov; 100(11):E1484-90. PubMed ID: 26323024
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanism of action of a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor on apolipoprotein B-100 kinetics in visceral obesity.
    Chan DC; Watts GF; Barrett PH; Mori TA; Beilin LJ; Redgrave TG
    J Clin Endocrinol Metab; 2002 May; 87(5):2283-9. PubMed ID: 11994377
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of lovastatin therapy on very-low-density lipoprotein triglyceride metabolism in subjects with combined hyperlipidemia: evidence for reduced assembly and secretion of triglyceride-rich lipoproteins.
    Arad Y; Ramakrishnan R; Ginsberg HN
    Metabolism; 1992 May; 41(5):487-93. PubMed ID: 1588827
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of extended-release niacin on the postprandial metabolism of Lp(a) and ApoB-100-containing lipoproteins in statin-treated men with type 2 diabetes mellitus.
    Ooi EM; Watts GF; Chan DC; Pang J; Tenneti VS; Hamilton SJ; McCormick SP; Marcovina SM; Barrett PH
    Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2686-93. PubMed ID: 26515419
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolic abnormalities of apolipoprotein B-containing lipoproteins in non-insulin-dependent diabetes: a stable isotope kinetic study.
    Duvillard L; Pont F; Florentin E; Galland-Jos C; Gambert P; Vergès B
    Eur J Clin Invest; 2000 Aug; 30(8):685-94. PubMed ID: 10964160
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute hyperinsulinemia decreases the hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 in NIDDM.
    Cummings MH; Watts GF; Umpleby AM; Hennessy TR; Kelly JM; Jackson NC; Sönksen PH
    Diabetes; 1995 Sep; 44(9):1059-65. PubMed ID: 7657029
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of HMG-CoA reductase by atorvastatin decreases both VLDL and LDL apolipoprotein B production in miniature pigs.
    Burnett JR; Wilcox LJ; Telford DE; Kleinstiver SJ; Barrett PH; Newton RS; Huff MW
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2589-600. PubMed ID: 9409231
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In-vivo metabolism of VLDL-apolipoprotein-B, -CIII and -E in normolipidemic subjects.
    Dinkel RE; Barrett PH; Demant T; Parhofer KG
    Nutr Metab Cardiovasc Dis; 2006 Apr; 16(3):215-21. PubMed ID: 16580589
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of ezetimibe on the in vivo kinetics of apoB-48 and apoB-100 in men with primary hypercholesterolemia.
    Tremblay AJ; Lamarche B; Cohn JS; Hogue JC; Couture P
    Arterioscler Thromb Vasc Biol; 2006 May; 26(5):1101-6. PubMed ID: 16528005
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interrelationships between human apolipoprotein A-I and apolipoproteins B-48 and B-100 kinetics using stable isotopes.
    Welty FK; Lichtenstein AH; Barrett PH; Dolnikowski GG; Schaefer EJ
    Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1703-7. PubMed ID: 15242863
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduced very-low-density lipoprotein fractional catabolic rate in apolipoprotein C1-deficient mice.
    Jong MC; van Ree JH; Dahlmans VE; Frants RR; Hofker MH; Havekes LM
    Biochem J; 1997 Jan; 321 ( Pt 2)(Pt 2):445-50. PubMed ID: 9020879
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma lipids, lipoproteins and post-heparin lipases in ponies with hyperlipaemia.
    Watson TD; Burns L; Love S; Packard CJ; Shepherd J
    Equine Vet J; 1992 Sep; 24(5):341-6. PubMed ID: 1396507
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma markers of cholesterol homeostasis and apolipoprotein B-100 kinetics in the metabolic syndrome.
    Chan DC; Watts GF; Barrett PH; O'Neill FH; Thompson GR
    Obes Res; 2003 Apr; 11(4):591-6. PubMed ID: 12690090
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between skeletal muscle fat content and very-low-density lipoprotein-apolipoprotein B-100 transport in obesity: effect of weight loss.
    Chan DC; Gan SK; Wong AT; Barrett PH; Watts GF
    Diabetes Obes Metab; 2014 Oct; 16(10):994-1000. PubMed ID: 24821431
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Equine hypothyroidism: the long term effects of thyroidectomy on metabolism and growth in mares and stallions.
    Lowe JE; Baldwin BH; Foote RH; Hillman RB; Kallfelz FA
    Cornell Vet; 1974 Apr; 64(2):276-95. PubMed ID: 4826263
    [No Abstract]   [Full Text] [Related]  

  • 38. Apolipoproteins C-III and A-V as predictors of very-low-density lipoprotein triglyceride and apolipoprotein B-100 kinetics.
    Chan DC; Watts GF; Nguyen MN; Barrett PH
    Arterioscler Thromb Vasc Biol; 2006 Mar; 26(3):590-6. PubMed ID: 16410456
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of a high-carbohydrate, low-saturated-fat diet on apolipoprotein B and triglyceride metabolism in Pima Indians.
    Abbott WG; Swinburn B; Ruotolo G; Hara H; Patti L; Harper I; Grundy SM; Howard BV
    J Clin Invest; 1990 Aug; 86(2):642-50. PubMed ID: 2200808
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of NIDDM on very-low-density lipoprotein triglyceride and apolipoprotein B metabolism. Studies before and after sulfonylurea therapy.
    Taskinen MR; Beltz WF; Harper I; Fields RM; Schonfeld G; Grundy SM; Howard BV
    Diabetes; 1986 Nov; 35(11):1268-77. PubMed ID: 3530855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.